Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

March 01, 1969; Volume 5,Issue 2

Articles

  • You have access
    The Half-Life of Alanine Aminotransferase and of Total Soluble Protein in Livers of Normal and Glucocorticoid-Treated Rats
    YEE S. KIM
    Molecular Pharmacology March 1969, 5 (2) 105-108;
  • You have access
    Studies on the Rate of Reduction of Hepatic Microsomal Cytochrome P-450 by Reduced Nicotinamide Adenine Dinucleotide Phosphate: Effect of Drug Substrates
    PHILIPPE L. GIGON, THEODORE E. GRAM and JAMES R. GILLETTE
    Molecular Pharmacology March 1969, 5 (2) 109-122;
  • You have access
    Studies on the Relationship between the Effects of Various Substances on Absorption Spectrum of Cytochrome P-450 and the Reduction of p-Nitrobenzoate by Mouse Liver Microsomes
    HENRY A. SASAME and JAMES R. GILLETTE
    Molecular Pharmacology March 1969, 5 (2) 123-130;
  • You have access
    Changes in Michaelis and Spectral Constants for Aniline in Hepatic Microsomes from Phenobarbital-Treated Rats
    A. M. GUARINO, T. E. GRAM, P. L. GIGON, F. E. GREENE and J. R. GILLETTE
    Molecular Pharmacology March 1969, 5 (2) 131-136;
  • You have access
    Azahomoaminopterin, a New Type of Folic Acid Antimetabolite
    K. SLAVÍK, V. SLAVÍKOVÁ, K. MOTYČKA, E. HERMANOVÁ, J. SOUČEK, Z. TOMSOVÁ, M. ŠPUNDOVÁ and E. NOVÁKOVÁ
    Molecular Pharmacology March 1969, 5 (2) 137-147;
  • You have access
    Nuclear Magnetic Resonance Study of the Interaction between Acetylcholine and Horse Serum Cholinesterase
    G. KATO
    Molecular Pharmacology March 1969, 5 (2) 148-155;
  • You have access
    The Specificity of Drug Receptors
    H. F. MARLOW, J. C. METCALFE and A. S. V. BURGEN
    Molecular Pharmacology March 1969, 5 (2) 156-165;
  • You have access
    The Structural Features Determining the Affinity of Haptens for an Antibody Binding Acetylcholine
    H. F. MARLOW, J. C. METCALFE and A. S. V. BURGEN
    Molecular Pharmacology March 1969, 5 (2) 166-173;
  • You have access
    Induction of Drug Metabolism
    N. E. SLADEK and G. J. MANNERING
    Molecular Pharmacology March 1969, 5 (2) 174-185;
  • You have access
    Induction of Drug Metabolism
    N. E. SLADEK and G. J. MANNERING
    Molecular Pharmacology March 1969, 5 (2) 186-199;
  • You have access
    A Mechanism for the Action of Penicillamine in the Treatment of Wilson’s Disease
    J. PEISACH and W. E. BLUMBERG
    Molecular Pharmacology March 1969, 5 (2) 200-209;
  • You have access
    Evidence for the Presence of a Chromogranin-like Protein in Bovine Splenic Nerve Granules
    P. BANKS, KAREN B. HELLE and D. MAYOR
    Molecular Pharmacology March 1969, 5 (2) 210-212;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 5, Issue 2
1 Mar 1969
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Sign up for alerts

Jump to

  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics